hero image
Dr. Camille Lemieux - University Health Network. Toronto, ON, CA

Dr. Camille Lemieux Dr. Camille Lemieux

Associate Director, Department of Infection Prevention and Control | University Health Network

Toronto, ON, CANADA

A recognized leader in infection control and patient safety

Social

Biography

Insert Biography Here

Industry Expertise (4)

Health and Wellness Health Care - Services Health Care - Providers Health Care - Facilities

Areas of Expertise (8)

Mandatory Flu Vaccinations Flu Vaccines Flu Prevention Patient Safety Epidemiology Hospital Acquired Infections Change Management Public Health Policy

Education (4)

University of Toronto: MPH, Public Health 2012

University of Ottawa: LLB, Law 2001

Queen's University: MD, Medicine 1993

University of Toronto: BPharm, Pharmacy 1984

Media Appearances (3)

The case against mandatory flu vaccination for health care workers

The Toronto Star  online

2014-07-28

There has been a good deal of recent media attention regarding what some see as a medical and ethical imperative that health-care workers be vaccinated against influenza. This view stems from two conclusions: vaccinating health-care workers protects patients from influenza-related harm, and current strategies have not been successful in achieving high vaccination rates...

view more

We need a better flu vaccine before considering mandatory vaccination of health care workers

CMAJ  online

2013-03-25

However, the effectiveness of the influenza vaccine is now being challenged, write Drs. Michael Gardam and Camille Lemieux from the Infection Prevention and Control Unit, University Health Network and the University of Toronto, Toronto, Ontario. A number of recent evidence reviews and vaccine effectiveness studies have found that the influenza vaccine is only moderately effective — about 60% — in healthy adults; this number can be much lower during some flu seasons...

view more

Flu season has hsopital ERs scrambling across GTA

The Toronto Star  online

2013-01-16

“The magnitude of this outbreak is not comparable to those, but the lessons learned have allowed us to be confident in our approach to infection control,” he said. University Health Network associate director of infection prevention and control Dr. Camille Lemieux said it’s been a decade since numbers have been so high in non-pandemic situations...

view more

Articles (5)

Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999–2009 Journal of Antimicrobial Chemotherapy

2013-01-01

Vancomycin-resistant enterococci (VRE) can be associated with serious bacteraemia. The focus of this study was to characterize the molecular epidemiology of VRE from bacteraemia cases that were isolated from 1999 to 2009 as part of Canadian ...

view more

Outbreak of multidrug‐resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design Infection Control and Hospital Epidemiology

2009-01-01

Pseudomonas aeruginosa has been increasingly recognized for its ability to cause significant hospital-associated outbreaks, particularly since the emergence of multidrug-resistant strains. Biofilm formation allows the pathogen to persist in ...

view more

Healthcare - Associated Infections as Patient Safety Indicators Healthcare Papers

2009-01-01

Healthcare-associated infections (HAIs) are a pressing and imminent patient safety concern as they cause substantial preventable morbidity and mortality. Despite this, there is a strong tendency for healthcare administrators and providers to view them as far ...

view more

Transmission of influenza A in human beings The Lancet

2007-01-01

Planning for the next influenza pandemic is occurring at many levels throughout the world, spurred on by the recent spread of H5N1 avian influenza in Asia, Europe, and Africa. Central to these planning efforts in the health-care sector are strategies to minimise the ...

view more

Interindividual and intraindividual variability in acetylation: Characterization with caffeine Clinical Pharmacology & Therapeutics

1988-01-01

The degree of interindividual and intraindividual variability in acetylator activity was investigated with caffeine used as a probe of enzyme activity. Acetylator phenotype and relative N-acetyltransferase activity were estimated in 46 subjects by measuring the ...

view more

Contact